Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Molina Healthcare, Inc. (NYSE: MOH), a FORTUNE 500 company that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. These regulatory documents offer detailed insight into how Molina reports its operations, capital structure, and material events.
Among the key filings are Form 8-K current reports, where Molina discloses material developments. Recent 8-Ks describe the private offering of 6.500% Senior Notes due 2031, including interest terms, maturity, ranking, redemption features, and the related indenture. Other 8-Ks outline a new revolving credit facility, amendments to the company’s credit agreement, and a delayed draw term loan used to partially fund a stock repurchase program.
Additional 8-K filings furnish earnings releases for specific quarters, summarizing premium revenue, total revenue, net income, medical care costs, medical care ratios, and segment performance for Medicaid, Medicare, and marketplace operations. These reports also include reconciliations of non-GAAP measures such as adjusted net income, EBITDA, and Adjusted EBITDA, along with explanations of how these metrics are calculated and their limitations.
Investors can also review filings that discuss Medicaid and CHIP contract developments, such as the Notice of Agency Decision indicating an intent to award Molina Healthcare of Florida a Statewide Medicaid Managed Care and Children’s Health Insurance Program contract for the Children’s Medical Services Program. These documents help explain how new or renewed contracts may affect membership and premium revenue.
On Stock Titan, Molina Healthcare’s filings are updated as they are released on EDGAR, and AI-powered summaries highlight the main terms, financial impacts, and segment implications of each document. This allows users to quickly understand complex credit agreements, debt offerings, and earnings disclosures without reading every page of the underlying filing.
BlackRock, Inc. has filed an amended Schedule 13G reporting beneficial ownership of Molina Healthcare common stock as of December 31, 2025. BlackRock reports beneficial ownership of 3,524,452 shares of Molina Healthcare, representing 6.9% of the outstanding common stock.
BlackRock has sole voting power over 3,296,986 shares and sole dispositive power over 3,524,452 shares, with no shared voting or dispositive power. The stake is held through various BlackRock business units and underlying clients, and no single other person has an interest in more than five percent of Molina’s outstanding common shares. BlackRock certifies that the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Molina Healthcare.
Molina Healthcare director reports quarterly stock grant under equity plan
A director of Molina Healthcare, Inc. received a grant of 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan, in connection with service as a director. The grant value was based on an annual equity award of $220,000 per director, with one quarter, or $55,000, granted on the first day of each quarter.
Because January 1, 2026 was a non-trading day, the share amount was calculated using the $173.54 closing price of Molina Healthcare common stock on December 31, 2025. Following this transaction, the reporting person beneficially owned 17,325 shares held by a family trust and 1,500 shares held in the reporting person’s 401(k) plan, all reported as indirect ownership.
Molina Healthcare, Inc. reported an insider equity award to one of its directors. On January 1, 2026, the director received 317 shares of common stock as a grant under the company’s 2025 Equity Incentive Plan for board service. The award represents one quarter of an annual equity value of $220,000, with this quarterly portion set at $55,000.
The number of shares was calculated using the common stock closing price of $173.54 on December 31, 2025. Following this grant, the director directly beneficially owns 3,742 shares of Molina Healthcare common stock.
Molina Healthcare director Ronna Romney, through the Ronna Romney Revocable Trust, received a grant of 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan for her services as a director. The quarterly grant amount was based on an equity value of $55,000, using the $173.54 closing price of Molina Healthcare’s common stock on December 31, 2025 because January 1 was a non-trading day.
Following this grant, the trust beneficially owns 17,733 shares of Molina Healthcare common stock. The filing indicates this Form 4 is for a single reporting person and reflects routine, formula-based director compensation rather than an open-market purchase or sale.
Molina Healthcare, Inc. reported that one of its directors received a grant of common stock as part of the company’s equity compensation program. On January 1, 2026, the director was granted 317 shares of Molina Healthcare common stock under the company’s 2025 Equity Incentive Plan for services as a director. The quarterly equity award was set at a dollar value of $55,000, determined by dividing that amount by the stock’s closing price of $173.54 on December 31, 2025, resulting in the 317-share grant. Following this transaction, the director beneficially owned 11,669 shares of Molina Healthcare common stock, held directly.
Molina Healthcare, Inc. reported that Director Richard C. Zoretic received a quarterly stock grant under the company’s 2025 Equity Incentive Plan for his board service. The award is part of an annual equity grant valued at $220,000 for each director, paid in four quarterly installments of $55,000.
For the quarter beginning January 1, 2026, the grant was set at 317 shares of common stock, calculated using the December 31, 2025 closing price of $173.54 because January 1 was a non-trading day. After this transaction, 7,947 shares of Molina Healthcare common stock are reported as beneficially owned indirectly through the Richard Charles Zoretic Revocable Living Trust.
Molina Healthcare director receives routine equity compensation in stock. A company director was granted 317 shares of Molina Healthcare common stock on January 1, 2026 under the 2025 Equity Incentive Plan, for services as a director. The grant represents one quarterly installment of an annual equity award with an aggregate value of $220,000, with this quarter’s portion set at $55,000. Because January 1, 2026 was a non-trading day, the shares were calculated using the December 31, 2025 closing price of $173.54 per share. Following this grant, the director beneficially owns 900 shares directly.
Molina Healthcare director reports routine stock grant
A director of Molina Healthcare, Inc. reported receiving 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan for board service. The quarterly grant represents one quarter of an annual equity award valued at $220,000, with this quarter’s $55,000 portion calculated using the $173.54 closing price of Molina Healthcare common stock on December 31, 2025, because January 1 was a non-trading day.
After this award, the reporting person beneficially owns 14,991 shares of Molina Healthcare common stock, held indirectly through the Dale B. Wolf Revocable Trust, for which he serves as sole trustee. The filing describes this as compensation for services as a director rather than an open-market purchase or sale.
Molina Healthcare, Inc. reported a routine equity grant to one of its directors. On January 1, 2026, the director received 317 shares of Molina common stock under the company’s 2025 Equity Incentive Plan as compensation for board service. The grant represents one quarterly portion of an annual equity award valued at $220,000, with this quarter’s installment set at $55,000.
The number of shares was calculated using the closing price of Molina’s common stock of $173.54 on December 31, 2025, because the grant date was a non‑trading day. Following this grant, the director beneficially owns 5,176 shares of Molina Healthcare common stock, held directly.
Molina Healthcare executive Debra Bacon, EVP of Medicaid, reported acquiring company stock through an employee plan. On December 31, 2025, she purchased 22 shares of common stock under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan. The purchase price was $147.51 per share, equal to 85% of $173.54, which was the closing price on the last trading day of the ESPP offering period. After this transaction, she beneficially owns 12,906 shares directly. The filing also notes a vesting schedule for previously granted shares, with tranches vesting on March 1, 2026, July 1, 2026, March 1, 2027, and March 1, 2028.
FAQ
What is the current stock price of Molina Hlthcare (MOH)?
What is the market cap of Molina Hlthcare (MOH)?
